Legal Representation
Attorney
Frank L. Politano
USPTO Deadlines
Application History
21 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 28, 2020 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Oct 28, 2020 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | Loading... |
| Apr 13, 2020 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Apr 13, 2020 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Apr 13, 2020 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Mar 2, 2020 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Mar 2, 2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Mar 2, 2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Aug 29, 2019 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Aug 29, 2019 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Aug 29, 2019 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jul 31, 2019 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jul 30, 2019 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jul 30, 2019 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jan 31, 2019 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jan 31, 2019 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jan 31, 2019 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jan 23, 2019 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 26, 2018 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Oct 25, 2018 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Oct 18, 2018 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Medicated creams and ointments for the treatment of dermatological conditions
First Use Anywhere:
Sep 30, 2014
First Use in Commerce:
Sep 30, 2014
Additional Information
Design Mark
The mark consists of a three-dimensional configuration of product packaging comprised of a large orange rectangle and a smaller blue rectangle horizontally placed on the side of a white tube of medication, not including the matter shown in dotted lines which is not part of the mark and serves only to show the position or placement of the mark.
Color Claim
The color(s) orange and blue on a white background is/are claimed as a feature of the mark.
Classification
International Classes
005